Highlights and Quick Summary
- Total liabilities for the quarter ending March 31, 2023 was $3.51 Million (a 20.47% increase compared to previous quarter)
- Year-over-year quarterly Total liabilities increased by 13.46%
- Annual Total liabilities for 2022 was $3.09 Million (a 0.0% decrease from previous year)
- Annual Total liabilities for 2022 was $3.09 Million (a 125.79% increase from previous year)
- Annual Total liabilities for 2021 was $1.37 Million (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total liabilities of Benitec Biopharma Limited
Most recent Total liabilitiesof BNTC including historical data for past 10 years.Interactive Chart of Total liabilities of Benitec Biopharma Limited
Benitec Biopharma Limited Total liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $3.51 | – | – | – | – |
| 2022 | $2.91 | $3.5 | $3.09 | $2.54 | $3.09 |
| 2021 | $3.18 | $2.36 | $1.37 | $2.5 | $1.37 |
| 2020 | $0.89 | $1.18 | $1.35 | $1.24 | $1.35 |
| 2019 | – | – | – | $1.06 | $2.64 |
| 2018 | – | – | – | – | $2.01 |
| 2017 | – | – | – | $1.37 | $0.87 |
| 2016 | – | $0.73 | $0.76 | $1.6 | $0.77 |
| 2015 | – | – | $0.72 | $1.37 | $1.37 |
| 2014 | – | – | $0.61 | $0.87 | $0.88 |
| 2013 | $1.14 | – | – | – | $1.14 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology